We thank the authors1 for their interest in our study2 and for their comments. Our study was designed to test the hypothesis that osteoarthritis (OA) at distant joints could predispose patients to develop inflammatory arthritis (IA) from immune checkpoint inhibitor therapy (ICI).
Cappelli et al. (Wed,) studied this question.